Canaccord Genuity reiterates Buy rating on Lovesac stock amid mixed outlook

The Lovesac Co. (LOVE) reported mixed fiscal second quarter results, with revenue slightly exceeding expectations and healthy gross margins, but a larger-than-expected loss per share. The furniture retailer also lowered its fiscal year 2026 adjusted EBITDA guidance due to anticipated tariff pressures and competitive discounting, contributing to a more than 13% stock decline over the past week. Despite this, Canaccord Genuity maintained its Buy rating, suggesting the current valuation at 0.4x forward revenue and approximately 5x adjusted EBITDA already reflects near-term macro challenges, though sustained revenue growth and gross margin stabilization are crucial for a stock rally.

Analysis

The Lovesac Co. (LOVE) presents a mixed financial profile following its fiscal second quarter results, triggering a significant negative market reaction with the stock declining over 13% in the past week. While the company achieved a second consecutive quarter of positive growth, with revenue of $160.5 million slightly exceeding expectations, this was overshadowed by a larger-than-expected loss per share of -$0.45, which missed analyst projections of -$0.27. A key concern for investors is the downward revision of the fiscal year 2026 adjusted EBITDA guidance, attributed to anticipated gross margin compression from tariff pressures and competitive discounting. In response, management is implementing countermeasures including vendor concessions, selective price increases, and supply chain diversification away from China. Despite these headwinds, Canaccord Genuity maintained its Buy rating, suggesting the current valuation at 0.4x forward revenue and approximately 5x adjusted EBITDA already reflects these near-term challenges. However, the firm notes that a sustained stock rally is contingent on achieving consistent revenue growth and, critically, gross margin stabilization.

Key Decisions for Investors

• Investors should weigh the stock's discounted valuation, noted at 0.4x forward revenue, against the significant near-term risks of margin compression from tariffs and competitive discounting which prompted the lowered EBITDA guidance.
• It is critical to monitor upcoming quarterly reports for signs of gross margin stabilization, as this has been identified as the primary catalyst required for a potential stock recovery, alongside consistent top-line growth.
• Consider the execution risk of management's mitigation strategies, such as vendor negotiations and price increases, as their effectiveness in offsetting margin pressure will be a key determinant of future profitability.